Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal
β Scribed by Valerio Nobili; Arun J. Sanyal
- Publisher
- Springer Japan
- Year
- 2011
- Tongue
- English
- Weight
- 205 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States. The association between NAFLD and quality of life (QOL) remains unclear. These data are important to estimate the burden of illness in NAFLD. The aim was to report QOL scores of adults with NAFLD
Background: With improvements in therapy for inflammatory bowel disease (IBD) and changes in the prevalence of obesity, the phenotype of Crohn's disease (CD) is changing. These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population. Methods: O